Insmed (INSM) Capital Expenditures (2011 - 2026)

Insmed's Capital Expenditures history runs 16 years deep, the most recent figure standing at $3.5 million for Q1 2026.

• In Q1 2026, Capital Expenditures fell 65.44% year-over-year to $3.5 million; the TTM figure through Mar 2026 stood at $26.0 million (down 4.92% YoY), while the FY2025 annual figure was $32.6 million, up 48.52% from the prior year.
• Capital Expenditures was $3.5 million for Q1 2026 at Insmed, down from $16.6 million in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $16.6 million in Q4 2025 to a low of $582000.0 in Q3 2022.
• Historically, Capital Expenditures has averaged $4.8 million across 5 years, with a median of $3.5 million in 2025.
• The sharpest annual moves came in 2023 and 2026: Capital Expenditures jumped 390.38% in 2023, then plunged 65.44% in 2026.
• A 5-year view of Capital Expenditures shows it stood at $4.7 million in 2022, then plunged by 54.1% to $2.2 million in 2023, then surged by 214.54% to $6.8 million in 2024, then surged by 144.96% to $16.6 million in 2025, then slumped by 79.02% to $3.5 million in 2026.
• The last three Capital Expenditures figures came in at $3.5 million (Q1 2026), $16.6 million (Q4 2025), and $2.4 million (Q3 2025), per Business Quant data.